Journal profile · Pharmacology & Pharmacy
Journal of Drug Delivery Science and Technology
ISSN 1773-2247 · eISSN 2588-8943 · Editions de Sante · FRANCE · Bimonthly · Founded 2004
Journal of Drug Delivery Science and Technology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.19; hybrid open access; APC about USD 3,810; review about 115 days (submission to acceptance, publisher); community-reported acceptance: easy; 1,256 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Drug Delivery Science and Technology is published by Editions de Sante and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Drug Delivery Systems, Nanoparticle-Based Drug Delivery and Advancements in Transdermal Drug Delivery, together about 37.7% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. It is the Offical Journal of the Association de Pharmacie Galenique Industrielle (APGI), Associazione Docenti e Ricercatori Italiani di Tecnologie e Legislazione Farmaceutiche (ADRITELF), and Academy of Pharmaceutical Science and Technology, Japan (APSTJ).The journal covers all innovative aspects of all pharmaceutical dosage forms and the most advanced research on: • Controlled release • Bioavailability and drug absorption • Nanomedicines • Gene delivery • Tissue engineering, etc.Hot topics, related to manufacturing processes and quality control, are also welcomed.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editorial board by country: 3 in mainland China (about 3%); most named United States 14, Italy 13, United Kingdom 8, Germany 6, Spain 6 (86 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics15.2%
- Nanoparticle-Based Drug DeliveryMaterials Science11.7%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics10.7%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics9.9%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5.4%
- Nanoplatforms for cancer theranosticsEngineering5.2%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science4%
- Graphene and Nanomaterials ApplicationsEngineering3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.19LetPub ·
- Impact factor (publisher)
- 5.2Publisher website ·
- CiteScore 2026-06
- 9.3LetPub ·
- CiteScore (publisher)
- 9.3Publisher website ·
- SJR 2026-06
- 0.78LetPub ·
- SNIP 2026-06
- 0.88LetPub ·
- h-index
- 38LetPub ·
- h-index
- 113OpenAlex ·
- i10-index
- 4,337OpenAlex ·
- 2-year mean citedness
- 4.35OpenAlex ·
- Self-citation rate
- 5.8%LetPub ·
- Share of gold OA articles
- 14.92%LetPub ·
Volume
- Articles per year
- 1,168LetPub ·
Articles by year OpenAlex count · 9,112 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 928 | 252 | 347 |
| 2025 | 1,256 | 263 | 4,049 |
| 2024 | 1,134 | 247 | 10,050 |
| 2023 | 1,079 | 202 | 16,635 |
| 2022 | 966 | 134 | 18,543 |
| 2021 | 689 | 74 | 16,930 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
115 dayssubmission to acceptance · community reports 6–12 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 42 daysPublisher website ·
- Submission to acceptance
- 115 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,810 / EUR 3,560 / GBP 3,050 / JPY 472,550 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Highlights
- Optional
- Graphical abstract
- Required
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Data availability
Data statement required at submission Model summary
To foster transparency, you are required to state the availability of any data at submission.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed, does not count as prior publication Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Editions de Sante
- Country or region
- FRANCE
- Language
- Multi-Language
- Frequency
- Bimonthly
- Founded
- 2004
- ISSN
- 1773-2247
- Electronic ISSN
- 2588-8943
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Drug Delivery Science and Technology
What CAS zone is Journal of Drug Delivery Science and Technology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Drug Delivery Science and Technology is in Zone 3 of Medicine, and in Zone 3 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Drug Delivery Science and Technology?
The latest impact factor listed by LetPub is 5.19; CiteScore 9.3, h-index 113.
How long does peer review take at Journal of Drug Delivery Science and Technology?
The publisher reports about 115 days (submission to acceptance); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Drug Delivery Science and Technology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Highlights: Optional; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Drug Delivery Science and Technology based?
Of the 86 board members whose country the journal's board page names, 3 (about 3%) are in mainland China; the countries named most often are United States (14), Italy (13) and United Kingdom (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Drug Delivery Science and Technology?
According to LetPub and DOAJ records, Journal of Drug Delivery Science and Technology is indexed in SCIE and Scopus.
Is Journal of Drug Delivery Science and Technology open access, and what is the APC?
Journal of Drug Delivery Science and Technology is a hybrid journal. For open-access publication: APC about USD 3,810.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .